Literature DB >> 12589451

[The molecular mechanisms of neovascular age-related macular degeneration].

D W Miller1, A M Joussen, F G Holz.   

Abstract

Age-related macular degeneration is the leading cause of irreversible vision loss in industrialized countries. While early forms of this disease with drusen and focal pigment alterations generally do not lead to relevant functional limitations, later forms of the disease, either through atrophy or choroidal neovascularization, are associated with significant visual impairment. A significant increase in knowledge about the molecular mechanisms of new vessel formation from the choriocapillaries has occurred over the past few years. This has already allowed for the clinical testing of pharmacological agents which inhibit the formation of new vessels in AMD. This article describes current research in the pathophysiology of choroidal neovascularization secondary to age-related macular degeneration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12589451     DOI: 10.1007/s00347-002-0760-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  6 in total

1.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

2.  Hyperthermia-induced upregulation of vascular endothelial growth factor in retinal pigment epithelial cells is regulated by mitogen-activated protein kinases.

Authors:  Hendrik Faby; Jost Hillenkamp; Johann Roider; Alexa Klettner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-22       Impact factor: 3.117

3.  [Transplantation of retinal pigment pithelium (RPE) following CNV removal in patients with AMD. Techniques, results, outlook].

Authors:  A Bindewald; F Roth; J Van Meurs; F G Holz
Journal:  Ophthalmologe       Date:  2004-09       Impact factor: 1.059

4.  Intravitreal bevacizumab therapy for neovascular age-related macular degeneration: a pilot study.

Authors:  Maura Lucy Abrahám-Marin; Carlos Fernando Cortés-Luna; Griselda Alvarez-Rivera; Myriam Hernández-Rojas; Hugo Quiroz-Mercado; Virgilio Morales-Cantón
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-09-28       Impact factor: 3.535

5.  Oxalomalate reduces expression and secretion of vascular endothelial growth factor in the retinal pigment epithelium and inhibits angiogenesis: Implications for age-related macular degeneration.

Authors:  Sung Hwan Kim; Hyunjin Kim; Hyeong Jun Ku; Jung Hyun Park; Hanvit Cha; Seoyoon Lee; Jin Hyup Lee; Jeen-Woo Park
Journal:  Redox Biol       Date:  2016-10-24       Impact factor: 11.799

6.  Fucoidan reduces secretion and expression of vascular endothelial growth factor in the retinal pigment epithelium and reduces angiogenesis in vitro.

Authors:  Michaela Dithmer; Sabine Fuchs; Yang Shi; Harald Schmidt; Elisabeth Richert; Johann Roider; Alexa Klettner
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.